Remacemide hydrochloride
SIGMA/SML0335 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 111686-79-4
Empirical Formula (Hill Notation): C17H20N2O · HCl
Molecular Weight: 304.81
MDL Number: MFCD00882179
Linear Formula: C17H20N2O · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C17H20N2O.ClH/c1-17(19 |
| InChI key | HYQMIUSWZXGTCC-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CC(Cc1ccccc1)(NC(=O)CN |
| solubility | H2O: >10 mg/mL |
| storage condition | desiccated |
| storage temp. | room temp |
| Biochem/physiol Actions: | Remacemide HCl is a low affinity NMDA antagonist with anticonvulsant properties. |
| Biochem/physiol Actions: | Remacemide HCl is a low affinity NMDA antagonist with anticonvulsant properties. Remacemide also been shown to block voltage-dependent sodium channels. |
| Biochem/physiol Actions: | Remacemide possesses neuroprotective and anti-epileptic actions. It supports reducing the frequency of seizures. Remacemide is also known to be a potential therapeutic for Huntington′s disease. |
| Features and Benefits: | This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | ![]() ![]() GHS05,GHS07,GHS09 |
| Signal word | Danger |
| Hazard statements | H302 - H318 - H400 |
| Precautionary statements | P273 - P280 - P301 + P312 + P330 - P305 + P351 + P338 + P310 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-41-50/53 |
| Safety Statements | 26-39-45-60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |




